MX2019009867A - Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae. - Google Patents

Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae.

Info

Publication number
MX2019009867A
MX2019009867A MX2019009867A MX2019009867A MX2019009867A MX 2019009867 A MX2019009867 A MX 2019009867A MX 2019009867 A MX2019009867 A MX 2019009867A MX 2019009867 A MX2019009867 A MX 2019009867A MX 2019009867 A MX2019009867 A MX 2019009867A
Authority
MX
Mexico
Prior art keywords
protein conjugates
polysaccharide
streptococcus pneumoniae
protein
pneumoniae polysaccharide
Prior art date
Application number
MX2019009867A
Other languages
English (en)
Inventor
He Jian
E Macnair John
A Winters Michael
G Joyce Joseph
ABEYGUNAWARDANA Chitrananda
Musey Luwy
Pujar Hari
M Skinner Julie
WEN Emily
Mchugh Patrick
Michael Williams John
Lancaster Catherine
J Smith William
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of MX2019009867A publication Critical patent/MX2019009867A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención proporciona composiciones inmunogénicas que tienen uno o más conjugados de polisacárido-proteína en los cuales uno o más polisacáridos de cápsulas bacterianas de Streptococcus pneumoniae se conjugan con una proteína vehículo en un solvente aprótico tal como dimetilsulfóxido (DMSO). La presente invención también proporciona métodos para proporcionar una respuesta inmunitaria mejorada a una vacuna de conjugado de polisacárido-proteína neumococo que comprende administrar a un sujeto humano una composición inmunogénica que comprende conjugados de polisacárido-proteína preparados en condiciones de DMSO.
MX2019009867A 2017-02-24 2018-02-20 Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae. MX2019009867A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762463216P 2017-02-24 2017-02-24
US201762555444P 2017-09-07 2017-09-07
PCT/US2018/018729 WO2018156491A1 (en) 2017-02-24 2018-02-20 Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates

Publications (1)

Publication Number Publication Date
MX2019009867A true MX2019009867A (es) 2019-10-02

Family

ID=63254065

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2019009867A MX2019009867A (es) 2017-02-24 2018-02-20 Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae.
MX2023001948A MX2023001948A (es) 2017-02-24 2019-08-19 Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae.
MX2023001947A MX2023001947A (es) 2017-02-24 2019-08-19 Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2023001948A MX2023001948A (es) 2017-02-24 2019-08-19 Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae.
MX2023001947A MX2023001947A (es) 2017-02-24 2019-08-19 Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae.

Country Status (10)

Country Link
US (4) US11090374B2 (es)
EP (1) EP3589314A4 (es)
JP (2) JP2020514326A (es)
KR (2) KR20240011879A (es)
CN (1) CN110337307A (es)
AU (1) AU2018225099A1 (es)
BR (1) BR112019017560A2 (es)
CA (1) CA3050120A1 (es)
MX (3) MX2019009867A (es)
WO (1) WO2018156491A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150061019A (ko) * 2005-04-08 2015-06-03 와이어쓰 엘엘씨 다가 폐렴구균 다당류-단백질 접합체 조성물
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR102049826B1 (ko) 2014-01-21 2019-12-03 화이자 인코포레이티드 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
CN108367063A (zh) * 2015-07-21 2018-08-03 辉瑞公司 包含缀合的荚膜糖抗原的免疫原性组合物及其试剂盒和用途
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CN110225764A (zh) 2017-01-31 2019-09-10 默沙东公司 制备多糖-蛋白缀合物的方法
CN110225757A (zh) 2017-01-31 2019-09-10 默沙东公司 由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
US11400162B2 (en) 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
MX2020002556A (es) 2017-09-07 2020-07-13 Merck Sharp & Dohme Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
JP2020533437A (ja) * 2017-09-07 2020-11-19 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用
US11524076B2 (en) 2017-09-07 2022-12-13 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
US11395849B2 (en) 2017-09-07 2022-07-26 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CN111683678B (zh) 2017-12-06 2024-01-26 默沙东有限责任公司 包含肺炎链球菌多糖蛋白缀合物的组合物及其使用方法
KR20210002641A (ko) 2018-04-30 2021-01-08 머크 샤프 앤드 돔 코포레이션 디메틸술폭시드 중의 동결건조된 돌연변이체 디프테리아 독소의 균질 용액을 제공하는 방법
TWI788610B (zh) 2018-12-19 2023-01-01 美商默沙東有限責任公司 包含肺炎鏈球菌多醣-蛋白質結合物之組合物及其使用方法
EP3952906A1 (en) * 2019-04-10 2022-02-16 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
BR112021024393A8 (pt) * 2019-06-05 2023-01-31 Merck Sharp & Dohme Um conjugado de polissacarídeo-proteína pneumocócico de sorotipo 35b imunogênico e processo de conjugação para fabricar o mesmo
CN110804097B (zh) * 2019-10-30 2021-02-26 云南沃森生物技术股份有限公司 一种同时制备两种单克隆抗体的方法
US20230093267A1 (en) * 2020-02-03 2023-03-23 Anagog Ltd. Distributed Content Serving
US20230405137A1 (en) 2020-11-10 2023-12-21 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CA3221075A1 (en) 2021-05-28 2022-12-01 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN114965784B (zh) * 2022-06-01 2023-10-27 艾美探索者生命科学研发有限公司 多糖活化度的测定方法
WO2024059161A1 (en) * 2022-09-16 2024-03-21 Merck Sharp & Dohme Llc Method for quantification of polysaccharide content in conjugate vaccines

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220198D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Modified saccharides,conjugates thereof and their manufacture
KR20150061019A (ko) 2005-04-08 2015-06-03 와이어쓰 엘엘씨 다가 폐렴구균 다당류-단백질 접합체 조성물
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP3466982B1 (en) 2005-04-08 2020-06-17 Wyeth LLC Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation
US7955605B2 (en) * 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) * 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
TW200806315A (en) 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
PT2074221E (pt) 2006-10-10 2010-09-06 Wyeth Llc Métodos melhorados para a separação de polissacáridos tipo 3 de streptococcus pneumoniae
PL3406635T3 (pl) 2007-03-23 2022-08-22 Wyeth Llc Skrócony sposób oczyszczania do wytwarzania polisacharydów otoczkowych Streptococcus pneumoniae
US8540955B2 (en) 2007-07-10 2013-09-24 Wyeth Llc Process for producing aluminum phosphate
CN102257127B (zh) 2008-12-18 2014-01-01 惠氏有限责任公司 使用二氧化碳控制肺炎链球菌多糖分子量的方法
PT2379734T (pt) 2008-12-18 2018-04-27 Wyeth Llc Método para o controlo da massa molecular do polissacárido do serotipo 19a de streptococcus pneumoniae
SG10201406432RA (en) * 2009-06-22 2014-11-27 Wyeth Llc Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
TW201136603A (en) 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
HUE048398T2 (hu) 2010-06-04 2020-07-28 Wyeth Llc Vakcinakészítmények
MX2013006539A (es) 2010-12-10 2013-07-22 Merck Sharp & Dohme Formulaciones novedosas que mitigan la agregacion inducida por agitacion de composiciones inmunogenicas.
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
KR20140075201A (ko) * 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CA2943263C (en) 2012-12-20 2018-12-04 Pfizer Inc. Glycoconjugation process
EP4286000A3 (en) 2014-01-21 2024-02-14 Pfizer Inc. Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
EP3096785B1 (en) * 2014-01-21 2020-09-09 Pfizer Inc Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR102049826B1 (ko) * 2014-01-21 2019-12-03 화이자 인코포레이티드 스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
EP3177325B1 (en) * 2014-08-08 2020-04-01 GlaxoSmithKline Biologicals S.A. Modified host cells and hybrid oligosaccharides for use in bioconjugate production
HRP20230416T1 (hr) * 2015-01-15 2023-07-07 Pfizer Inc. Imunogeni pripravci, namijenjeni upotrebi u cjepivima protiv pneumokoka
PE20180172A1 (es) 2015-05-04 2018-01-22 Pfizer Conjugados proteina-polisacarido de estreptococo grupo b, metodos para producir conjugados, composiciones inmunogenas que comprenden conjugados y sus usos
CN108367063A (zh) * 2015-07-21 2018-08-03 辉瑞公司 包含缀合的荚膜糖抗原的免疫原性组合物及其试剂盒和用途
AU2016357567B2 (en) 2015-11-17 2020-05-07 Pfizer Inc. Media and fermentation methods for producing polysaccharides in bacterial cell culture
JP6884145B2 (ja) 2015-11-20 2021-06-09 ファイザー・インク 肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物
BR112019001971A2 (pt) 2016-08-05 2019-05-07 Sanofi Pasteur, Inc. composição conjugada de polissacarídeo-proteína pneumocócica multivalente
JP7186166B2 (ja) * 2016-12-30 2022-12-08 バックスサイト・インコーポレイテッド 非天然アミノ酸とのポリペプチド抗原接合体
MX2019008564A (es) 2017-01-20 2019-09-19 Pfizer Composiciones inmunogenicas para su uso en vacunas neumococicas.
CN110225764A (zh) 2017-01-31 2019-09-10 默沙东公司 制备多糖-蛋白缀合物的方法
CN110225757A (zh) 2017-01-31 2019-09-10 默沙东公司 由肺炎链球菌血清型19f生产荚膜多糖蛋白缀合物的方法
WO2018156467A1 (en) 2017-02-24 2018-08-30 Merck Sharp & Dohme Corp. Methods for improving filterability of polysaccharide-protein conjugate reactions
US11219680B2 (en) 2017-02-24 2022-01-11 Merck Sharp & Dohme Corp. Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
EP3585803A4 (en) 2017-02-24 2020-11-11 Merck Sharp & Dohme Corp. PNEUMOCOCCIC CONJUGATE VACCINE FORMULATIONS
EP3668541A4 (en) 2017-08-16 2021-05-26 Merck Sharp & Dohme Corp. FORMULATIONS FOR PNEUMOCOCCAL CONJUGATE VACCINE
MX2020002556A (es) 2017-09-07 2020-07-13 Merck Sharp & Dohme Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
EP3678654A4 (en) * 2017-09-07 2021-04-21 Merck Sharp & Dohme Corp. ANTIPNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN POLYSACCHARIDE-CARRIER PROTEIN IMMUNOGENIC CONJUGATES
JP2020533299A (ja) 2017-09-07 2020-11-19 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． キャリアタンパク質へのコンジュゲーションのための肺炎球菌多糖の製剤方法
US11395849B2 (en) 2017-09-07 2022-07-26 Merck Sharp & Dohme Llc Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
JP2020533437A (ja) * 2017-09-07 2020-11-19 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用
US20200325020A1 (en) 2017-10-25 2020-10-15 Merck Sharp & Dohme Corp. Adjuvanted vaccines
CN111683678B (zh) * 2017-12-06 2024-01-26 默沙东有限责任公司 包含肺炎链球菌多糖蛋白缀合物的组合物及其使用方法
JP2021522285A (ja) 2018-04-30 2021-08-30 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． リオスフィアから肺炎連鎖球菌莢膜多糖類キャリアタンパク質コンジュゲートを生産する方法
CN112074293A (zh) 2018-04-30 2020-12-11 默沙东公司 生产肺炎链球菌荚膜多糖载体蛋白缀合物的方法
KR20210002641A (ko) 2018-04-30 2021-01-08 머크 샤프 앤드 돔 코포레이션 디메틸술폭시드 중의 동결건조된 돌연변이체 디프테리아 독소의 균질 용액을 제공하는 방법
WO2019236435A1 (en) 2018-06-07 2019-12-12 Merck Sharp & Dohme Corp. Lyosphere critical reagent kit
WO2020121159A1 (en) 2018-12-12 2020-06-18 Pfizer Inc. Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
TWI788610B (zh) 2018-12-19 2023-01-01 美商默沙東有限責任公司 包含肺炎鏈球菌多醣-蛋白質結合物之組合物及其使用方法
EP3952906A1 (en) 2019-04-10 2022-02-16 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2021014948A (es) 2019-06-05 2022-01-24 Merck Sharp & Dohme Llc Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
BR112021024393A8 (pt) 2019-06-05 2023-01-31 Merck Sharp & Dohme Um conjugado de polissacarídeo-proteína pneumocócico de sorotipo 35b imunogênico e processo de conjugação para fabricar o mesmo

Also Published As

Publication number Publication date
KR20190121330A (ko) 2019-10-25
US11090374B2 (en) 2021-08-17
AU2018225099A1 (en) 2019-07-25
MX2023001947A (es) 2023-03-14
MX2023001948A (es) 2023-03-14
US20210330778A1 (en) 2021-10-28
KR20240011879A (ko) 2024-01-26
US20240139303A1 (en) 2024-05-02
EP3589314A1 (en) 2020-01-08
RU2019129503A (ru) 2021-03-24
US20210330777A1 (en) 2021-10-28
JP2023036953A (ja) 2023-03-14
US20200054733A1 (en) 2020-02-20
RU2019129503A3 (es) 2021-06-25
WO2018156491A1 (en) 2018-08-30
CN110337307A (zh) 2019-10-15
EP3589314A4 (en) 2021-04-21
JP2020514326A (ja) 2020-05-21
BR112019017560A2 (pt) 2020-04-07
CA3050120A1 (en) 2018-08-30

Similar Documents

Publication Publication Date Title
MX2023001948A (es) Inmunogenicidad mejorada de conjugados de polisacarido-proteina de streptococcus pneumoniae.
MX2022014850A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MX2022009927A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
MX2022009928A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
NZ755769A (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MX2020002555A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
PH12020550891A1 (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
MX2016009469A (es) Polisacaridos capsulares de streptococcus pneumoniae y conjugados de los mismos.
PH12017501898A1 (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
MX2019003593A (es) Composiciones de vacuna neumococica multivalente que comprenden conjugados de polisacaridos y proteinas.
WO2020131763A3 (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
IN2014DN09791A (es)
EA201990451A1 (ru) Композиция многовалентных пневмококковых конъюгатов капсульного полисахарида с белком-носителем и ее применение
MX2020002084A (es) Conjugados de peptido, proceso de conjugacion y usos de los mismos.
BR112017028395A2 (pt) ?polissacarídeo capsular bacteriano, conjugado, e, composição farmacêutica?